Gilvetmab

Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.

E-SE® (Selenium, Vitamin E)

OTOMAX® Otic Ointment

A powerful first-line, broad-spectrum topical medication administered twice a day for 7 days to treat otitis external in dogs.